BNR Stock Analysis: Buy, Sell, or Hold?
BNR - Burning Rock Biotech Limited American Depositary Shares
$8.95
-0.19 (-2.08%)
âŧ
5d:
-6.82%
30d:
+18.39%
90d:
-57.09%
WAIT
LOW Confidence
Analysis Updated: Jul 23, 2026 12:00 AM ET
Earnings: Sep 14, 2026
Get Alerted When BNR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: BNR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: BNR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: BNR is currently trading at $8.95, which is considered fair relative to its 30-day fair value range of $7.94 to $10.57.
Technical Outlook: Technically, BNR is in a strong downtrend. Immediate support is located at $8.68, while resistance sits at $11.49.
Market Sentiment: BNR has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. However, the stock is trading significantly above the average Wall Street target of $4.03. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BNR is in a strong downtrend. Immediate support is located at $8.68, while resistance sits at $11.49.
Market Sentiment: BNR has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. However, the stock is trading significantly above the average Wall Street target of $4.03. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$7.94 -
$10.57
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
39.5%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 55.0% above Wall St target ($4.03)
Trading Range Analysis
30-Day Trading Range
$7.94 -
$10.57
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$8.68
Resistance Level
$11.49
Current Trend
Strong Downtrend
Technical data as of
Jul 23, 2026
Fundamental Context
Wall Street Target
$4.03
(-55.0%)
Revenue Growth (YoY)
-18.9%
Profit Margin
-11.5%
Share & Embed Analysis
Last updated: July 25, 2026 7:24 PM ET
Data refreshes hourly during market hours. Next update: 8:24 PM
Data refreshes hourly during market hours. Next update: 8:24 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BNR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Yusheng Han
BUY
314870 shares
2026-03-31
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher ScientificâĻ |
STRONG BUY
31 analysts |
$591 | 61 BUY |
|
EXAS
EXACT Sciences CorporatiâĻ |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$243 | 57 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$171 | 53 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$280 | 56 HOLD |
